XML 57 R33.htm IDEA: XBRL DOCUMENT
v3.25.2

Material Accounting Policies (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2025
Material Accounting Policies [Abstract] |
Schedule of Classification and Measurements of Financial Assets and Liabilities | Summary of the Company’s classification and measurements of financial assets and liabilities:
Financial Assets and Liabilities |  | Classification |  | Measurement
Cash and cash equivalents |  | Amortized cost |  | Amortized cost
Restricted cash |  | Amortized cost |  | Amortized cost
Other receivables |  | Amortized cost |  | Amortized cost
Investment in Psyence Labs Ltd |  | FVTPL |  | Fair value
Accounts payable and accrued liabilities |  | Amortized cost |  | Amortized cost
Derivative warrant liability |  | FVTPL |  | Fair value
Convertible note liability |  | FVTPL |  | Fair value
Due to NCAC Sponsor |  | FVTPL |  | Fair value
Due to Psyence Group Inc |  | FVTPL |  | Fair value
​Schedule of Change in Presentation Currency | The change in presentation currency is a voluntary change which is accounted for retrospectively. For comparative reporting purposes, historical financial information has been translated to United States dollars which is disclosed in the tables below:
Change in presentation currency |  | March 31, 2023 Reported CAD $ |  |  | Foreign Currency Translation |  |  | March 31, 2023 Restated USD $ |
EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Net equity |  |  | (271,275 | ) |  |  | 70,830 |  |  |  | (200,445 | )
NET DEFICIT |  |  | (271,275 | ) |  |  | 70,830 |  |  |  | (200,445 | )
Change in presentation currency |  | March 31, 2022 Reported CAD $ |  |  | Foreign Currency Translation |  |  | March 31, 2022 Restated USD $ |
EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Net equity |  |  | 2,122,696 |  |  |  | (423,996 | ) |  |  | 1,698,700 |
NET DEFICIT |  |  | 2,122,696 |  |  |  | (423,996 | ) |  |  | 1,698,700 |
Change in presentation currency |  | March 31, 2023 Reported CAD $ |  |  | Foreign Currency Translation |  |  | March 31, 2023 Restated USD $ |
Expenses |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 9,292 |  |  |  | (2,263 | ) |  |  | 7,029 |
Research and development |  |  | 2,126,762 |  |  |  | (517,867 | ) |  |  | 1,608,895 |
General and administrative |  |  | 484,382 |  |  |  | (117,947 | ) |  |  | 366,435 |
Professional and consulting fees |  |  | 1,655,663 |  |  |  | (403,153 | ) |  |  | 1,252,510 |
Loss before other items |  |  | (4,276,099 | ) |  |  | 1,041,230 |  |  |  | (3,234,869 | )
Other items |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 2,054 |  |  |  | (500 | ) |  |  | 1,554 |
Foreign exchange gain |  |  | 35,574 |  |  |  | (8,662 | ) |  |  | 26,912 |
NET LOSS |  |  | (4,238,471 | ) |  |  | 1,032,068 |  |  |  | (3,206,403 | )
Change in presentation currency |  | March 31, 2023 Reported CAD $ |  |  | Foreign Currency Translation |  |  | March 31, 2023 Restated USD $ |
Net loss |  |  | (4,238,471 | ) |  |  | 1,032,068 |  |  |  | (3,206,403 | )
Non-cash adjustment: |  |  |  |  |  |  |  |  |  |  |  |
Share based compensation |  |  | 292,756 |  |  |  | (71,469 | ) |  |  | 221,287 |
Foreign exchange |  |  | - |  |  |  | (84,499 | ) |  |  | (84,499 | )
Changes in working capital: |  |  |  |  |  |  |  |  |  |  |  |
Other receivables |  |  | (152,778 | ) |  |  | 42,920 |  |  |  | (109,858 | )
Prepaids |  |  | (97,547 | ) |  |  | 25,882 |  |  |  | (71,665 | )
Accounts payable and accrued liabilities |  |  | 2,258,967 |  |  |  | (599,909 | ) |  |  | 1,659,058 |
Cash used in operating activities |  |  | (1,937,073 | ) |  |  | 344,993 |  |  |  | (1,592,080 | )
Proceeds received from Psyence Group Inc |  |  | 1,551,744 |  |  |  | (378,821 | ) |  |  | 1,172,923 |
Cash provided from financing activities |  |  | 1,551,744 |  |  |  | (378,821 | ) |  |  | 1,172,923 |
Change in cash and cash equivalents |  |  | (385,329 | ) |  |  | (33,828 | ) |  |  | (419,157 | )
Cash and cash equivalents, start of year |  |  | 2,191,095 |  |  |  | (437,658 | ) |  |  | 1,753,437 |
Cash and cash equivalents, end of year |  |  | 1,805,765 |  |  |  | (471,486 | ) |  |  | 1,334,280 |

X
- Definition The description of the nature of changes in accounting estimates that have effects in the current period or are expected to have effects in future periods. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 8 -IssueDate 2024-01-01 -Paragraph 39 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_39&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfNatureAndAmountOfChangeInAccountingEstimate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pbm_MaterialAccountingPoliciesAbstract
Namespace Prefix: | pbm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the entity's classification and measurements of financial assets and liabilities. + References No definition available. + Details
Name: | pbm_ScheduleOfClassificationAndMeasurementsOfFinancialAssetsAndLiabilitiesTextBlock
Namespace Prefix: | pbm_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration